306 related articles for article (PubMed ID: 31290022)
1. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China.
Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J
Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
4. Managing antiphospholipid syndrome in pregnancy.
Schreiber K; Hunt BJ
Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
[TBL] [Abstract][Full Text] [Related]
5. Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes.
Castellanos Gutierrez AS; Figueras F; Espinosa G; Youssef L; Crispi F; Santana M; Nadal A; Baños N
Placenta; 2023 Aug; 139():92-98. PubMed ID: 37354691
[TBL] [Abstract][Full Text] [Related]
6. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Hoxha A; Tincani A; Nalli C; Marozio L; Maina A; Espinosa G; Ríos-Garcés R; Cervera R; Carolis S; Monteleone G; Latino O; Udry S; LLurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Trapé J; Ruiz-Hidalgo D; Sos L; Farran-Codina I;
Rheumatology (Oxford); 2020 Jun; 59(6):1306-1314. PubMed ID: 31580459
[TBL] [Abstract][Full Text] [Related]
8. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) and risk of obstetric anti-phospholipid syndrome.
Zhang X; Liu Z; Guo F; Wang Q; Bai W; Zhao A
Am J Reprod Immunol; 2023 Jun; 89(6):e13621. PubMed ID: 36181461
[TBL] [Abstract][Full Text] [Related]
9. Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis.
Bundhun PK; Soogund MZS; Huang F
BMC Pregnancy Childbirth; 2018 Jun; 18(1):212. PubMed ID: 29879927
[TBL] [Abstract][Full Text] [Related]
10. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report.
Alijotas-Reig J; Ferrer-Oliveras R;
Lupus; 2012 Jun; 21(7):766-8. PubMed ID: 22635227
[TBL] [Abstract][Full Text] [Related]
11. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Marozio L; Espinosa G; Cervera R; Ríos-Garcés R; De Carolis S; Latino O; LLurba E; Chighizola CB; Gerosa M; Pengo V; Lundelin K; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Hoxha A; Tabacco S; Stojanovich L; Gogou V; Varoudis A; Arnau A; Ruiz-Hidalgo D; Trapé J; Sos L; Stoppani C; Martí-Cañamares A; Farran-Codina I;
Autoimmun Rev; 2019 Apr; 18(4):406-414. PubMed ID: 30772493
[TBL] [Abstract][Full Text] [Related]
12. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome.
Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F
Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and pregnancy outcomes of non-criteria obstetric antiphospholipid syndrome].
Yang XX; Sun YD; Zhao JL; Tian XP; Zeng XF; Li MT
Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):812-816. PubMed ID: 34445817
[No Abstract] [Full Text] [Related]
14. Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications-a population-based study.
Rhein AK; Rabinovich A; Abuhasira R; Lubaton-Barshishat S; Erez O
Res Pract Thromb Haemost; 2024 May; 8(4):102430. PubMed ID: 38798792
[TBL] [Abstract][Full Text] [Related]
15. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
Sciascia S; Hunt BJ; Talavera-Garcia E; Lliso G; Khamashta MA; Cuadrado MJ
Am J Obstet Gynecol; 2016 Feb; 214(2):273.e1-273.e8. PubMed ID: 26429521
[TBL] [Abstract][Full Text] [Related]
16. Does seronegative obstetric APS exist? "pro" and "cons".
Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.
Sugawara E; Kato M; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Umazume T; Morikawa M; Watari H; Atsumi T
Lupus; 2019 Oct; 28(12):1407-1416. PubMed ID: 31551035
[TBL] [Abstract][Full Text] [Related]
18. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
[TBL] [Abstract][Full Text] [Related]
19. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study.
Li X; Deng X; Duan H; Zeng L; Zhou J; Liu C; Guo X; Liu X
Clin Rheumatol; 2021 Jan; 40(1):193-204. PubMed ID: 32514680
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
